Laurik, a direct-to-consumer neutraceutical brand, has raised ₹3.7 crore from investors. The start-up has raised the funds when it is still in the ideation stage.
The funding round was led by Murthy Aradhi, co-founder at FastCollab, and Lakshmikant PB, Director of Finance at Antler, an early-stage venture capital firm.
Lavanya Sunkari, Founder and CEO of Laurik, said the Indian nutraceuticals market is expected to grow at a compounded annual growth rate of 15 per cent in the next fives.
“We would like to utilise the funds to strengthen our research and development capacities, and expand the team size and scale our go-to-market operations,” she said.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.